Esther Carrasco

Title: Esther Carrasco: Innovator in Biopharmaceuticals

Introduction

Esther Carrasco is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of novel therapeutic compounds. With a total of 2 patents, her work focuses on addressing critical health conditions through innovative solutions.

Latest Patents

Esther's latest patents include groundbreaking research on pyridin-sulfonamide compounds for the treatment of conditions related to interleukin 1 beta. This invention relates to a new class of compounds that are useful as medicaments for diseases responsive to the inhibition of IL-1β, such as non-alcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). Additionally, she has developed p38 and JNK MAPK inhibitors aimed at treating and preventing degenerative diseases of the nervous system. These compounds are designed to bind to specific regions of mitogen-activated protein kinases, which are crucial for therapeutic applications.

Career Highlights

Esther Carrasco is currently associated with Allinky Biopharma, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on improving patient outcomes through effective treatments.

Collaborations

Esther collaborates with talented professionals in her field, including Miguel Vega and Patricia Gómez. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Esther Carrasco stands out as a leading inventor in the biopharmaceutical industry, with her patents reflecting her dedication to addressing significant health challenges. Her innovative work continues to pave the way for new therapeutic options that can improve the quality of life for many patients.